Cargando…
Rationale and design of the costs, health status and outcomes in community-acquired pneumonia (CHO-CAP) study in elderly persons hospitalized with CAP
BACKGROUND: Vaccine effectiveness is usually determined in randomized controlled trials (RCT) and if effective, additional information, e.g. on cost-effectiveness, is required to allow evidence-based decision making. A prerequisite for proper health economic modelling is the availability of good qua...
Autores principales: | Mangen, Marie-Josée J, Bonten, Marc JM, de Wit, G Ardine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880048/ https://www.ncbi.nlm.nih.gov/pubmed/24354588 http://dx.doi.org/10.1186/1471-2334-13-597 |
Ejemplares similares
-
Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study
por: Vissink, Conrad E., et al.
Publicado: (2016) -
Erratum to: Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study
por: Vissink, Conrad E., et al.
Publicado: (2016) -
The impact of community-acquired pneumonia on the health-related quality-of-life in elderly
por: Mangen, Marie-Josée J., et al.
Publicado: (2017) -
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design
por: Angus, Derek C., et al.
Publicado: (2020) -
The Science of Selecting Antimicrobials for Community-Acquired Pneumonia (CAP)
por: File, Thomas M.
Publicado: (2009)